Bjørn H. Ebdrup
Bjørn H. Ebdrup
Professor, Consultant Psychiatrist, Centre for Neuropsychiatric Schizophrenia Research, CNSR
Adresse e-mail validée de cnsr.dk
Titre
Citée par
Citée par
Année
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
4552017
Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia
BH Ebdrup, B Glenthøj, H Rasmussen, B Aggernaes, AR Langkilde, ...
Journal of psychiatry & neuroscience: JPN 35 (2), 95, 2010
1202010
Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia
H Rasmussen, D Erritzoe, R Andersen, BH Ebdrup, B Aggernaes, ...
Archives of General Psychiatry 67 (1), 9-16, 2010
1112010
Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms
BH Ebdrup, A Skimminge, H Rasmussen, B Aggernaes, B Oranje, ...
International Journal of Neuropsychopharmacology 14 (1), 69-82, 2011
762011
Serotonin 2A receptor antagonists for treatment of schizophrenia
BH Ebdrup, H Rasmussen, J Arnt, B Glenthøj
Expert opinion on investigational drugs 20 (9), 1211-1223, 2011
692011
Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users
L Baandrup, BH Ebdrup, JØ Rasmussen, J Lindschou, C Gluud, ...
Cochrane Database of Systematic Reviews, 2018
632018
Sensorimotor gating and habituation in antipsychotic-naive, first-episode schizophrenia patients before and after 6 months’ treatment with quetiapine
B Aggernaes, BY Glenthoj, BH Ebdrup, H Rasmussen, H Lublin, B Oranje
The The International Journal of Neuropsychopharmacology 13 (10), 1383-1395, 2010
632010
Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review
BH Ebdrup, H Nørbak, S Borgwardt, B Glenthøj
Curr Med Chem 20 (3), 438-47; DOI: 10.2174/0929867311320030015, 2013
602013
Striatal reward activity and antipsychotic-associated weight change in patients with schizophrenia undergoing initial treatment
MØ Nielsen, E Rostrup, S Wulff, B Glenthøj, BH Ebdrup
JAMA psychiatry 73 (2), 121-128, 2016
532016
Glucagon‐like peptide‐1 receptor agonists for antipsychotic‐associated cardio‐metabolic risk factors: A systematic review and individual participant data meta‐analysis
D Siskind, M Hahn, CU Correll, A Fink‐Jensen, AW Russell, N Bak, ...
Diabetes, Obesity and Metabolism 21 (2), 293-302, 2019
512019
P50 suppression and its neural generators in antipsychotic-naive first-episode schizophrenia before and after 6 months of quetiapine treatment
B Oranje, B Aggernaes, H Rasmussen, BH Ebdrup, BY Glenthøj
Schizophrenia bulletin 39 (2), 472-480, 2013
512013
Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade
BH Ebdrup, JM Raghava, MØ Nielsen, E Rostrup, B Glenthøj
Journal of psychiatry & neuroscience: JPN 41 (2), 133, 2016
462016
The influence of impaired processing speed on cognition in first-episode antipsychotic-naive schizophrenic patients
R Andersen, B Fagerlund, H Rasmussen, BH Ebdrup, B Aggernaes, ...
European Psychiatry 28 (6), 332-339, 2013
452013
Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine
H Rasmussen, BH Ebdrup, D Erritzoe, B Aggernaes, B Oranje, J Kalbitzer, ...
Psychopharmacology 213 (2), 583-592, 2011
422011
Adverse cardiac events in out‐patients initiating clozapine treatment: a nationwide register‐based study
C Rohde, C Polcwiartek, K Kragholm, BH Ebdrup, D Siskind, J Nielsen
Acta Psychiatrica Scandinavica 137 (1), 47-53, 2018
402018
Effect of GLP‐1 Receptor Agonist Treatment on Body weight in Obese Antipsychotic‐treated Patients with Schizophrenia: a Randomized, Placebo‐controlled Trial
PL Ishøy, FK Knop, BV Broberg, N Bak, UB Andersen, NR Jørgensen, ...
Diabetes, Obesity and Metabolism, 2016
382016
Brain connectivity studies in schizophrenia: unravelling the effects of antipsychotics
A B Nejad, B H Ebdrup, B Y Glenthoj, H R Siebner
Current neuropharmacology 10 (3), 219-230, 2012
382012
Impaired temporoparietal deactivation with working memory load in antipsychotic-naive patients with first-episode schizophrenia
AB Nejad, BH Ebdrup, HR Siebner, H Rasmussen, B Aggernæs, ...
The World Journal of Biological Psychiatry 12 (4), 271-281, 2011
362011
Patterns of white matter microstructure in individuals at ultra-high-risk for psychosis: associations to level of functioning and clinical symptoms
K Krakauer, BH Ebdrup, BY Glenthøj, JM Raghava, D Nordholm, ...
Psychological Medicine 47 (15), 2689-2707, 2017
322017
Structural brain correlates of sensorimotor gating in antipsychotic-naive men with first-episode schizophrenia
TB Hammer, B Oranje, A Skimminge, B Aggernæs, BH Ebdrup, B Glenthøj, ...
Journal of psychiatry & neuroscience: JPN 38 (1), 34, 2013
302013
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20